Mr. Wilkinson has accepted the position of president and CEO at Impax Laboratories. He was appointed president of Actavis Global R&D in January.
Actavis develops and manufactures pharmaceutical products. The company’s North American branded pharmaceuticals business is focused primarily on women’s health, urology, gastroenterology and dermatology.
More Articles on Gastroenterology:
9 Statistics on Gastroenterologist Compensation by Location
AGA Calls for More Transparency From CMS
The Growing Role of Biologics in Gastroenterology
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
